Light you can't see, reaching tissue nothing else can.
Photobiomodulation (PBM) uses non-ionizing electromagnetic radiation in the red (620–700nm) and near-infrared (700–1100nm) spectrum to modulate cellular function. The primary chromophore is cytochrome c oxidase (CCO, Complex IV of the mitochondrial electron transport chain). Photon absorption by CCO displaces inhibitory nitric oxide, increases electron transport rate, elevates mitochondrial membrane potential, and upregulates ATP synthesis. Secondary effects include transient ROS generation (hormetic signaling), NO release (vasodilation), and modulation of intracellular calcium.
Near-infrared light therapy uses specific wavelengths of light — invisible to the eye but felt as gentle warmth — to boost your cells' energy production. The light passes through skin and tissue to reach your mitochondria (your cells' power plants), where it directly increases ATP (cellular energy) production. The deeper the light penetrates, the more tissue it can reach.
CCO photon absorption at 620–680nm and 760–830nm dissociates inhibitory NO from the binuclear center, restoring O2 binding and electron flow through Complex IV. This increases the proton gradient across the inner mitochondrial membrane, driving ATP synthase. Measured ATP increases of 20–50% in treated tissue.1
Light hits the energy factories in your cells and directly boosts their output. Like cleaning a clogged air filter — the machinery works better when the blockage (nitric oxide) is removed.1
Photodissociation of NO from CCO and other metalloproteins releases bioactive nitric oxide into surrounding tissue. NO is a potent vasodilator, increasing local blood flow and oxygen delivery. Also acts as a signaling molecule for inflammation resolution and wound healing.2
The light releases nitric oxide — a molecule that widens blood vessels, increasing blood flow to the treated area. More blood flow means more oxygen and nutrients, faster healing.2
Brief, controlled ROS elevation from PBM activates Nrf2 transcription factor, upregulating antioxidant response elements (ARE), including SOD, catalase, and glutathione peroxidase. Same hormetic principle as HBOT but via photonic rather than hyperoxic pathway.3
A small burst of reactive molecules tells your cells to strengthen their defenses — same principle as exercise making muscles stronger. The light creates a tiny, controlled stress that triggers a disproportionately large protective response.3
Transcranial PBM at 810nm penetrates the skull with ~2–5% transmission, sufficient for therapeutic effect on cortical tissue. Increases cerebral blood flow, BDNF expression, and synaptogenesis. Reduces neuroinflammation via microglial modulation. Demonstrated improvements in TBI,5 depression,4 and cognitive performance in healthy adults.8
PBM upregulates fibroblast proliferation, collagen synthesis (types I and III), and TGF-β signaling. Accelerates wound healing through enhanced angiogenesis (via VEGF) and extracellular matrix remodeling. Extensively documented in wound healing, post-surgical recovery, and dermatological applications.6
The light stimulates the cells that build and repair tissue — increasing collagen production, growing new blood vessels, and accelerating wound healing. Well-documented for skin healing, surgical recovery, and injury repair.6
The therapeutic window of PBM corresponds to the optical absorption spectra of CCO and the relative transparency of biological tissue. Water, melanin, and hemoglobin absorption define the boundaries. Penetration depth is a function of wavelength, tissue type, and irradiance.
Different wavelengths of light penetrate to different depths. Shorter wavelengths (visible red) are absorbed near the surface. Longer wavelengths (near-infrared) pass through skin, fat, and muscle to reach deep tissue.
| Wavelength | Band | Penetration | Applications |
|---|---|---|---|
| 620–700nm | Visible red | 1–2cm | Skin, superficial wounds, dermatology |
| 700–770nm | Transition | 2–3cm | Shallow musculature, joints |
| 780–850nm | Near-infrared | 3–5cm | Deep tissue, organs, bone |
| 810nm | NIR | ~2–5% transcranial | Most-studied wavelength for brain applications |
| 850nm | NIR | 4–5cm | Peak deep-tissue penetration with strong CCO absorption |
PBM follows the Arndt-Schulz law: a biphasic dose response where low doses stimulate, high doses inhibit. The therapeutic window is typically 1–50 J/cm² depending on tissue depth and target. Subtherapeutic fluence fails to activate CCO-mediated signaling. Excessive fluence generates supraphysiologic ROS, overwhelming antioxidant capacity and producing inhibitory rather than stimulatory effects. This biphasic curve explains inconsistencies in the literature when protocol parameters are poorly controlled.
More is not always better. Light therapy follows a curve: too little does nothing, the right amount triggers healing, and too much actually becomes counterproductive. This is why professional-grade devices with calibrated output matter — and why treatment duration is precise, not guesswork.
Deep tissue therapy using high-irradiance NIR devices at 820–850nm that penetrate 3–5cm into tissue — reaching muscle, joint, and bone that surface-level devices cannot. Irradiance exceeding 850 mW/cm² with continuous motion to distribute therapeutic fluence across the treatment area, avoiding thermal hotspots while maintaining optimal J/cm² delivery.Powerful enough to reach deep tissue, kept in constant motion during treatment to distribute the energy evenly.
Transcranial photobiomodulation at 810nm for brain health applications — intranasal and transcranial delivery for direct photonic access to prefrontal cortex, default mode network nodes, and vagal afferents via auricular stimulation.direct stimulation of the brain through the skull and nasal passages, plus vagal nerve stimulation through the ear.
Sessions are part of an integrated protocol alongside hyperbaric oxygen therapy — the two modalities share downstream pathways (NF-κB suppression, Nrf2 activation, mitochondrial biogenesis, VEGF-mediated angiogenesisinflammation reduction, antioxidant defense, new mitochondria and blood vessel growth) and are designed to compound.